Gilead (NASDAQ: GILD ) will be reporting 4Q earnings on Monday, as well as the company's full 2012 results. In this video, Motley Fool health-care analyst David Williamson tells us why it has been a transformational year for the company, and what key things to watch for in the upcoming earnings report.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report, "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.